MedCity News » Cancer Treatment

Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own dia...

https://medcitynews.com/2022/12/avendas-platform-for-personalized-prostate-cancer-mapping-earns-fda-clearance/

CAR-T has become increasingly recognized as an exciting and potentially paradigm-shifting treatment in the past five years. In fact, more than 10,000 patients have undergone this new treatmen...

https://medcitynews.com/2022/10/5-years-after-fda-approval-car-t-treatment-looks-like-the-future-of-medicine/

With a global epidemic of obesity and diabetes and their known relationship to cancer, researchers and oncologists are turning their attention to metabolic hormones as promising new targets f...

https://medcitynews.com/2021/01/are-metabolic-hormones-the-next-frontier-in-cancer-treatment/

The MedCity CONVERGE conference at the University City Science Center June 19 in Philadelphia will be the scene of a dynamic series of conversations around cancer treatment, precision medicin...

https://medcitynews.com/2019/05/innovation-in-cancer-treatment-conference/

Engineering researchers at the University of Michigan have developed a battery-operated injectable computer with a radio antenna that can transmit data to a device located up to 12 inches out...

https://medcitynews.com/2016/06/injectable-computer-tumor-pressure/

So where are we with CAR-T? Is it the innovative, transformative, disruptive, paradigm-changing cancer therapy we all hope for, or is it another incremental improvement? The post Will CAR-T del...

https://medcitynews.com/2016/06/will-car-t-deliver/

Patients with previously treated advanced renal cell carcinoma have a new treatment option with cabozantinib — a kinase inhibitor shown to improve overall survival compared to everolimus, as a ...

https://medcitynews.com/2016/06/asco-renal-cell-carcinoma/

The FDA issued an alert about the drug on Monday, and in the warning it warned healthcare professionals that the drug is not approved for previously untreated chronic lymphocytic leukemia. ...

https://medcitynews.com/2016/03/gilead-sciences-pulls-the-reigns-six-trials-for-its-cancer-drug-zydelig-following-concerns-of-adverse-effects-and-deaths/

Oncora Medical’s approach provides clinical decision support for radiation oncologists to reduce radiation toxicity and guide more personalized treatments. The post Health IT company raises $...

https://medcitynews.com/2016/03/clinical-decision-support-and-radiation-therapy/

Under the terms of the agreement, Onxeo is acquiring DNA Therapeutics for an upfront payment of nearly $1.85 million in common shares at deal closing. The post Onxeo announces acquisition o...

https://medcitynews.com/2016/02/onexo-announces-acquisition-of-dna-therapeutics-to-further-develop-its-cancer-treatment-plan/

Future topics will include lower back pain, ADHD and type 2 diabetes. The post How will new cancer treatment care guides help patients navigate the healthcare system? appeared first on Med...

https://medcitynews.com/2016/01/patient-care-guides/

Medtronic takes over the OsteoCool device for treating cancers that metastasize to the spine, created by Baylis Medical. The post Medtronic acquires tech from Baylis Medical for its FDA app...

https://medcitynews.com/2016/01/medtronic-acquires-baylis-medical-after-osteocool-spine-cancer-device-gets-fda-approval/

The startup created from Dana-Farber Cancer Institute announced today the closing of a $73 million Series A round of financing and a promising partnership with Roche. The post C4 Therapeutics l...

https://medcitynews.com/2016/01/c4-therapeutics-launches-with-73m-series-a-for-new-cancer-treatment-approach/

Flagship Ventures has launched new company Evelo Therapeutics, which will be using an understanding of the microbiome to created targeted cancer treatment. The post Leveraging the power of the ...

https://medcitynews.com/2015/11/leveraging-the-power-of-the-microbiome-a-new-source-for-targeted-cancer-therapy/

Patients who have recurrent or metastatic solid tumors that are not responding to standard treatment could soon receive helpful treatment with the help of a GSK and Merck joined effort. The pos...

https://medcitynews.com/2015/11/gsk-and-merck-joining-forces-for-potential-cancer-treatment/

Blogging will be light today on MedCity News – most of the staff is off for the Columbus Day holiday. The post Morning Read: Merck KGaA’s oncology revolution, a litmus test on biotech IPOs ...

https://medcitynews.com/2015/10/morning-read-merck-kgaas-oncology-revolution-a-litmus-test-on-biotech-ipos/

Also, Teva talks drug prices; security wonks talk medical device hacks, and ugly talk at the Anthem-Aetna hearings. The post Morning Read: Sean Parker bets big on cancer treatment appeared fir...

https://medcitynews.com/2015/09/morning-read-sean-parker-cancer-treatment/

The Waltham, Massachusetts-based drug company has pulled in a huge chunk of funding to help develop its cancer treatment. The post Deciphera raises $75M directed toward kinase-inhibiting cancer...

https://medcitynews.com/2015/09/deciphera-raises-75m-directed-toward-kinase-inhibiting-cancer-drug/

Bottom line: If you reimburse for patient navigation then not everyone will be able to get it. The post Health insurance reimbursement for patient navigators? No thank you appeared first on Me...

https://medcitynews.com/2015/07/patient-navigators-reimbursement/

In a joint press release, NantHealth and Allscripts said that they would jointly integrate their software via application provider interfaces The post Allscripts invests $200M in Soon-Shiong’...

https://medcitynews.com/2015/06/allscripts-invests-200m-in-soon-shiongs-nanthealth/

An NIH study has shown that giving HIV drugs when patients are initially diagnosed with the disease is more effective than waiting for the white blood cell counts to drop. The post NIH study sh...

https://medcitynews.com/2015/05/juno-therapeutics-editas-greece-cancer-treatment/

Not everyone knew the anesthesia came for free. The post Free colonoscopy should come with free anesthesia (will more people get them)? appeared first on MedCity News .

https://medcitynews.com/2015/05/free-colonoscopy-comes-free-anesthesia-will-people-get-worth-watching/

When Americans talk, pharmaceutical companies listen. And what they’ve heard is that initiatives to contain or regulate medical costs get labeled as “rationing,” a word with very un-Ame...

https://medcitynews.com/2015/04/pharma-gets-dont-cheap-drugs-unamerican/

Biotech company Aura Biosciences has secured a $21 million Series B round of funding led by financing from Advent Life Sciences and both new and previous investors. The company is focused on usin...

https://medcitynews.com/2015/03/aura-biosciences-pulls-21m-tumor-targeted-rare-eye-cancer-therapies/

With information from one of the most intense cancer research studies ever conducted (surveying 25.7 million people), it’s clear that where you live has something to do with how likely you are ...

https://medcitynews.com/2014/12/will-beat-cancer-depends-live/

#MIS2014 Innovation #5 – antibody drug conjugates. Again! Idea around for 30 years, but antibodies better, humanized, understand targets. — Meghana Keshavan (@meghanakeshavan) October 29, 201...

https://medcitynews.com/2014/10/cleveland-clinics-top-10-medical-innovations-2015/

A Livestrong Foundation challenge launched earlier this year to confront some of the challenges that prevent cancer patients from getting the treatment they need has whittled down the competing c...

https://medcitynews.com/2014/09/livestrong-cancer-tech-competition/

It would be oversimplified to call it the power of positive thinking, but Harvard Medical School Professor Ted Kaptchuk‘s talk at TEDMED 2014 in Washington D.C., highlighted compelling research...

https://medcitynews.com/2014/09/tedmed-talk-placebo-effect-highlights-benefits-balancing-hands-care-engagement-treatment/

It’s not every entrepreneur who hatches an idea for a business with her mother, let alone when they’re hiking up Mount Kilimanjaro. Away from daily distractions like email and a smartphone is...

https://medcitynews.com/2014/08/canceriq-wants-to-make-genetic-testing-for-cancer-more-accessible-with-clinical-decision-support-tool/

  A new study has found that a teledermatology platform using a dermoscope adapter can speed up referrals of suspicious lesions and rashes to dermatologists for possible surgery. The findings we...

https://medcitynews.com/2014/07/study-using-teledermatology-speeds-up-skin-cancer-triage/